Semaglutide is a powerful tool in the fight against obesity and can be an effective aid in weight loss when used in conjunction with a comprehensive medical weight loss program
This injectable solution works by destroying fat cells, which are then naturally eliminated by the body, resulting in a more sculpted and contoured appearance over time
Gaschler MM, Andia AA, Liu H et al (2018) FINO(2) initiates ferroptosis through GPX4 inactivation and iron oxidation
In January of this year, the FDA noted that it had "received adverse event reports after patients used compounded semaglutide" and that "patients should not use a compounded drug if an approved drug is available to treat a patient." In July, the agency followed up with a notice that it had "received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products." And in August, Eli Lilly, the maker of Zepbound and Mounjaro, sent a series of cease-and-desist letters to providers urging them to stop prescribing compounded versions of those drugs